Medroxyprogesterone-acetate | hsa00030 | Pentose phosphate pathway | 8.97E-03 | 1 | P11413 | G6PD | More | |
Medroxyprogesterone-acetate | hsa00052 | Galactose metabolism | 1.03E-02 | 2 | P06280, O43451 | GLA, MGAM | More | |
Medroxyprogesterone-acetate | hsa00220 | Arginine biosynthesis | 4.88E-02 | 1 | P49448 | GLUD2 | More | |
Medroxyprogesterone-acetate | hsa00250 | Alanine, aspartate and glutamate metabolism | 4.88E-02 | 1 | P49448 | GLUD2 | More | |
Medroxyprogesterone-acetate | hsa00380 | Tryptophan metabolism | 4.14E-02 | 1 | Q16613 | AANAT | More | |
Medroxyprogesterone-acetate | hsa00471 | D-Glutamine and D-glutamate metabolism | 1.65E-02 | 1 | P49448 | GLUD2 | More | |
Medroxyprogesterone-acetate | hsa00480 | Glutathione metabolism | 1.35E-02 | 1 | P11413 | G6PD | More | |
Medroxyprogesterone-acetate | hsa00500 | Starch and sucrose metabolism | 1.67E-02 | 2 | O43451, P06737 | MGAM, PYGL | More | |
Medroxyprogesterone-acetate | hsa00533 | Glycosaminoglycan biosynthesis - keratan sulfate | 3.43E-02 | 1 | Q9NY97 | B3GNT2 | More | |
Medroxyprogesterone-acetate | hsa00561 | Glycerolipid metabolism | 2.51E-02 | 2 | P51648, P23743 | ALDH3A2, DGKA | More | |
Medroxyprogesterone-acetate | hsa00562 | Inositol phosphate metabolism | 7.30E-04 | 4 | P27987, Q96PE3, P19174, P42338 | ITPKB, INPP4A, PLCG1, PIK3CB | More | |
Medroxyprogesterone-acetate | hsa00590 | Arachidonic acid metabolism | 3.85E-02 | 2 | P11712, P09960 | CYP2C9, LTA4H | More | |
Medroxyprogesterone-acetate | hsa00591 | Linoleic acid metabolism | 4.07E-02 | 1 | P11712 | CYP2C9 | More | |
Medroxyprogesterone-acetate | hsa00620 | Pyruvate metabolism | 2.51E-02 | 2 | P40925, P51648 | MDH1, ALDH3A2 | More | |
Medroxyprogesterone-acetate | hsa00630 | Glyoxylate and dicarboxylate metabolism | 1.25E-05 | 2 | P40925, P15104 | MDH1, GLUL | More | |
Medroxyprogesterone-acetate | hsa00730 | Thiamine metabolism | 5.29E-03 | 2 | P05186, P24666 | ALPL, ACP1 | More | |
Medroxyprogesterone-acetate | hsa00910 | Nitrogen metabolism | 4.88E-02 | 1 | P49448 | GLUD2 | More | |
Medroxyprogesterone-acetate | hsa00980 | Metabolism of xenobiotics by cytochrome P450 | 9.14E-03 | 2 | P78417, P11712 | GSTO1, CYP2C9 | More | |
Medroxyprogesterone-acetate | hsa00982 | Drug metabolism - cytochrome P450 | 9.14E-03 | 2 | P11712, P78417 | CYP2C9, GSTO1 | More | |
Medroxyprogesterone-acetate | hsa00983 | Drug metabolism - other enzymes | 2.44E-02 | 2 | P32320, P05164 | CDA, MPO | More | |
Medroxyprogesterone-acetate | hsa01100 | Metabolic pathways | 4.12E-02 | 12 | P15104, P51648, P42338, Q96PE3, P19174, P27987, Q13370, P40925, P23743, P43034, P09917, Q53FZ2 | GLUL, ALDH3A2, PIK3CB, INPP4A, PLCG1, ITPKB, PDE3B, MDH1, DGKA, PAFAH1B1, ALOX5, ACSM3 | More | |
Medroxyprogesterone-acetate | hsa01200 | Carbon metabolism | 2.91E-02 | 1 | P11413 | G6PD | More | |
Medroxyprogesterone-acetate | hsa01210 | 2-Oxocarboxylic acid metabolism | 3.43E-02 | 1 | P50213 | IDH3A | More | |
Medroxyprogesterone-acetate | hsa01521 | EGFR tyrosine kinase inhibitor resistance | 7.30E-04 | 4 | Q92529, P19174, P42338, Q9NRA1 | SHC3, PLCG1, PIK3CB, PDGFC | More | |
Medroxyprogesterone-acetate | hsa03008 | Ribosome biogenesis in eukaryotes | 4.94E-02 | 2 | P19784, P67870 | CSNK2A2, CSNK2B | More | |
Medroxyprogesterone-acetate | hsa03013 | RNA transport | 8.18E-05 | 9 | P38919, Q15287, Q9UBU9, P37198, P35658, P63279, P55884, O15371, P20042 | EIF4A3, RNPS1, NXF1, NUP62, NUP214, UBE2I, EIF3B, EIF3D, EIF2S2 | More | |
Medroxyprogesterone-acetate | hsa03040 | Spliceosome | 3.23E-03 | 9 | O60508, P08579, Q15427, P38159, P61978, Q07955, Q01130, P11142, Q9Y2W2 | CDC40, SNRPB2, SF3B4, RBMX, HNRPK, SFRS1, SFRS2, HSPA8, WBP11 | More | |
Medroxyprogesterone-acetate | hsa03050 | Proteasome | 1.40E-02 | 1 | P55036 | PSMD4 | More | |
Medroxyprogesterone-acetate | hsa03060 | Protein export | 4.83E-05 | 3 | Q15070, P37108, Q15005 | OXA1L, SRP14, SPCS2 | More | |
Medroxyprogesterone-acetate | hsa04012 | ErbB signaling pathway | 8.84E-04 | 6 | P21860, Q92529, Q13557, P19174, O14944, P42338 | ERBB3, SHC3, CAMK2D, PLCG1, EREG, PIK3CB | More | |
Medroxyprogesterone-acetate | hsa04014 | Ras signaling pathway | 3.23E-05 | 9 | P42338, Q92529, P20827, Q9NRA1, P49767, Q13009, P63218, P50151, P19174 | PIK3CB, SHC3, EFNA1, PDGFC, VEGFC, TIAM1, GNG5, GNG10, PLCG1 | More | |
Medroxyprogesterone-acetate | hsa04015 | Rap1 signaling pathway | 3.91E-02 | 4 | Q9NRA1, P49767, P42338, P19174 | PDGFC, VEGFC, PIK3CB, PLCG1 | More | |
Medroxyprogesterone-acetate | hsa04020 | Calcium signaling pathway | 1.83E-06 | 14 | P27987, Q96DU7, Q08828, P45880, Q13557, P21860, P19174, P61073, P0DP24, P05141, P51828, P23634, Q9NRA1, P49767 | ITPKB, ITPKC, ADCY1, VDAC2, CAMK2D, ERBB3, PLCG1, CXCR4, CALM2, SLC25A5, ADCY7, ATP2B4, PDGFC, VEGFC | More | |
Medroxyprogesterone-acetate | hsa04022 | cGMP-PKG signaling pathway | 2.45E-03 | 8 | Q99941, P18848, P23634, Q08828, P51828, P05141, P45880, P0DP24 | CREBL1, ATF4, ATP2B4, ADCY1, ADCY7, SLC25A5, VDAC2, CALM2 | More | |
Medroxyprogesterone-acetate | hsa04024 | cAMP signaling pathway | 3.37E-02 | 3 | P63092, P26678, P61586 | GNAS, PLN, RHOA | More | |
Medroxyprogesterone-acetate | hsa04061 | Viral protein interaction with cytokine and cytokine receptor | 1.91E-02 | 3 | Q8NHW4, P61073, Q13651 | CCL4L2, CXCR4, IL10RA | More | |
Medroxyprogesterone-acetate | hsa04062 | Chemokine signaling pathway | 4.35E-03 | 6 | P07948, P42338, P19174, Q92529, P63218, P50151 | LYN, PIK3CB, PLCG1, SHC3, GNG5, GNG10 | More | |
Medroxyprogesterone-acetate | hsa04064 | NF-kappa B signaling pathway | 1.06E-05 | 15 | P10415, Q13489, O00463, Q13546, P01584, Q04759, Q9UDY8, Q16548, Q13315, P63279, P24522, Q8NHW4, P09341, Q9UNE0, Q9NQC7 | BCL2, BIRC3, TRAF5, RIPK1, IL1B, PRKCQ, MALT1, BCL2A1, ATM, UBE2I, GADD45A, CCL4L2, CXCL1, EDAR, CYLD | More | |
Medroxyprogesterone-acetate | hsa04070 | Phosphatidylinositol signaling system | 3.19E-04 | 5 | P19174, P42338, P23743, Q96PE3, P27987 | PLCG1, PIK3CB, DGKA, INPP4A, ITPKB | More | |
Medroxyprogesterone-acetate | hsa04071 | Sphingolipid signaling pathway | 7.26E-04 | 7 | P21453, Q9H228, P01375, Q13362, Q9BX95, P10415, Q9UQC2 | S1PR1, EDG8, TNF, PPP2R5C, SGPP1, BCL2, GAB2 | More | |
Medroxyprogesterone-acetate | hsa04072 | Phospholipase D signaling pathway | 1.65E-05 | 9 | P42338, Q92529, P61586, P19174, O14986, Q14344, P63092, P23743, Q9NRA1 | PIK3CB, SHC3, RHOA, PLCG1, PIP5K1B, GNA13, GNAS, DGKA, PDGFC | More | |
Medroxyprogesterone-acetate | hsa04080 | Neuroactive ligand-receptor interaction | 1.00E-02 | 7 | P08311, Q15722, P21453, Q9H228, O00398, P21730, P07550 | CTSG, LTB4R, S1PR1, EDG8, P2RY10, C5AR1, ADRB2 | More | |
Medroxyprogesterone-acetate | hsa04114 | Oocyte meiosis | 2.09E-03 | 9 | P51812, Q02750, Q13557, P0DP24, P16298, Q17RY0, Q08828, P51828, P27348 | RPS6KA3, MAP2K1, CAMK2D, CALM2, PPP3CB, CPEB4, ADCY1, ADCY7, YWHAQ | More | |
Medroxyprogesterone-acetate | hsa04120 | Ubiquitin mediated proteolysis | 6.89E-03 | 5 | Q14145, Q13042, Q13191, Q15751, Q7Z6Z7 | KEAP1, CDC16, CBLB, HERC1, HUWE1 | More | |
Medroxyprogesterone-acetate | hsa04137 | Mitophagy - animal | 2.52E-02 | 2 | P19784, P67870 | CSNK2A2, CSNK2B | More | |
Medroxyprogesterone-acetate | hsa04140 | Autophagy - animal | 3.19E-02 | 4 | P22694, Q14643, P10415, Q04759 | PRKACB, ITPR1, BCL2, PRKCQ | More | |
Medroxyprogesterone-acetate | hsa04141 | Protein processing in endoplasmic reticulum | 2.01E-03 | 8 | P07384, O95487, Q99941, O75460, P11142, Q9H3Z4, P07900, O95816 | CAPN1, SEC24B, CREBL1, ERN1, HSPA8, DNAJC5, HSP90AA1, BAG2 | More | |
Medroxyprogesterone-acetate | hsa04145 | Phagosome | 4.48E-02 | 5 | Q15080, P05164, O60603, P35443, P13765 | NCF4, MPO, TLR2, THBS4, HLA-DOB | More | |
Medroxyprogesterone-acetate | hsa04150 | mTOR signaling pathway | 3.60E-02 | 3 | Q02750, Q9NQL2, P51812 | MAP2K1, RRAGD, RPS6KA3 | More | |
Medroxyprogesterone-acetate | hsa04151 | PI3K-Akt signaling pathway | 1.09E-04 | 11 | P42338, P43657, P20827, Q9NRA1, P49767, P08238, P63218, P50151, O15335, Q13751, P14784 | PIK3CB, P2RY5, EFNA1, PDGFC, VEGFC, HSP90AB1, GNG5, GNG10, CHAD, LAMB3, IL2RB | More | |
Medroxyprogesterone-acetate | hsa04152 | AMPK signaling pathway | 2.34E-02 | 2 | Q96EB6, P36956 | SIRT1, SREBF1 | More | |
Medroxyprogesterone-acetate | hsa04210 | Apoptosis | 4.11E-03 | 9 | Q13315, P10415, O76075, P01375, Q9NR28, P24522, Q16548, P43234, Q14643 | ATM, BCL2, DFFB, TNF, DIABLO, GADD45A, BCL2A1, CTSO, ITPR1 | More | |
Medroxyprogesterone-acetate | hsa04211 | Longevity regulating pathway | 3.41E-03 | 7 | Q12778, Q08828, P51828, Q99941, P18848, Q9UEF7, Q96KQ7 | FOXO1, ADCY1, ADCY7, CREBL1, ATF4, KL, EHMT2 | More | |
Medroxyprogesterone-acetate | hsa04213 | Longevity regulating pathway - multiple species | 2.85E-02 | 2 | Q9Y4H2, Q13547 | IRS2, HDAC1 | More | |
Medroxyprogesterone-acetate | hsa04215 | Apoptosis - multiple species | 1.56E-02 | 2 | Q13489, P10415 | BIRC3, BCL2 | More | |
Medroxyprogesterone-acetate | hsa04217 | Necroptosis | 6.23E-04 | 10 | P01568, P23458, Q13489, Q9NQC7, Q13546, P05141, P01584, P0C0S5, Q13557, Q9H444 | IFNA21, JAK1, BIRC3, CYLD, RIPK1, SLC25A5, IL1B, H2AFZ, CAMK2D, CHMP4B | More | |
Medroxyprogesterone-acetate | hsa04261 | Adrenergic signaling in cardiomyocytes | 1.60E-03 | 7 | Q08828, P51828, Q99941, P18848, P0DP24, Q13557, P23634 | ADCY1, ADCY7, CREBL1, ATF4, CALM2, CAMK2D, ATP2B4 | More | |
Medroxyprogesterone-acetate | hsa04310 | Wnt signaling pathway | 4.17E-03 | 3 | P61586, P19784, P67870 | RHOA, CSNK2A2, CSNK2B | More | |
Medroxyprogesterone-acetate | hsa04330 | Notch signaling pathway | 2.46E-03 | 3 | Q92542, P49768, P46531 | NCSTN, PSEN1, NOTCH1 | More | |
Medroxyprogesterone-acetate | hsa04340 | Hedgehog signaling pathway | 2.61E-03 | 4 | P49841, P22694, Q13635, P10415 | GSK3B, PRKACB, PTCH1, BCL2 | More | |
Medroxyprogesterone-acetate | hsa04360 | Axon guidance | 1.50E-02 | 3 | P20827, P23528, Q06124 | EFNA1, CFL1, PTPN11 | More | |
Medroxyprogesterone-acetate | hsa04370 | VEGF signaling pathway | 8.20E-05 | 5 | P19174, P16298, P42338, Q05397, Q02750 | PLCG1, PPP3CB, PIK3CB, PTK2, MAP2K1 | More | |
Medroxyprogesterone-acetate | hsa04371 | Apelin signaling pathway | 1.24E-02 | 4 | P63218, P50151, Q13370, Q14344 | GNG5, GNG10, PDE3B, GNA13 | More | |
Medroxyprogesterone-acetate | hsa04380 | Osteoclast differentiation | 4.98E-02 | 4 | Q9NQC7, Q9UQC2, P23458, P01584 | CYLD, GAB2, JAK1, IL1B | More | |
Medroxyprogesterone-acetate | hsa04390 | Hippo signaling pathway | 2.08E-02 | 3 | P84022, Q13485, Q13489 | SMAD3, SMAD4, BIRC3 | More | |
Medroxyprogesterone-acetate | hsa04510 | Focal adhesion | 1.67E-03 | 8 | P42338, O14986, P61586, O15335, Q16363, Q9NRA1, P49767, Q92529 | PIK3CB, PIP5K1B, RHOA, CHAD, LAMA4, PDGFC, VEGFC, SHC3 | More | |
Medroxyprogesterone-acetate | hsa04520 | Adherens junction | 1.38E-04 | 3 | P19784, P67870, P61586 | CSNK2A2, CSNK2B, RHOA | More | |
Medroxyprogesterone-acetate | hsa04530 | Tight junction | 1.74E-03 | 6 | P63261, P16989, P56750, Q9Y478, Q92974, Q14247 | ACTG1, CSDA, CLDN17, PRKAB1, ARHGEF2, CTTN | More | |
Medroxyprogesterone-acetate | hsa04611 | Platelet activation | 4.11E-02 | 3 | P42338, Q14344, P07948 | PIK3CB, GNA13, LYN | More | |
Medroxyprogesterone-acetate | hsa04612 | Antigen processing and presentation | 4.48E-02 | 5 | P13765, P26715, P26717, Q13241, P01732 | HLA-DOB, KLRC1, KLRC2, KLRD1, CD8A | More | |
Medroxyprogesterone-acetate | hsa04613 | Neutrophil extracellular trap formation | 7.20E-05 | 16 | P11215, O60603, P05164, P08246, Q9UM07, Q13547, Q93077, P58876, P62807, Q16778, O60814, P68431, Q15080, P20160, P08311, P21730 | ITGAM, TLR2, MPO, ELA2, PADI4, HDAC1, HIST1H2AC, H2BC5, HIST1H2BC, HIST2H2BE, H2BC12, H3C1; H3C2; H3C3; H3C4; H3C6; H3C7; H3C8; H3C10; H3C11; H3C12, NCF4, AZU1, CTSG, C5AR1 | More | |
Medroxyprogesterone-acetate | hsa04620 | Toll-like receptor signaling pathway | 4.16E-02 | 2 | Q13546, P01568 | RIPK1, IFNA21 | More | |
Medroxyprogesterone-acetate | hsa04621 | NOD-like receptor signaling pathway | 5.35E-03 | 7 | P01568, Q13489, Q13546, P01375, P59665, P59666, P12838 | IFNA21, BIRC3, RIPK1, TNF, DEFA1; DEFA1B, DEFA3, DEFA4 | More | |
Medroxyprogesterone-acetate | hsa04622 | RIG-I-like receptor signaling pathway | 2.39E-02 | 2 | P01568, Q13546 | IFNA21, RIPK1 | More | |
Medroxyprogesterone-acetate | hsa04623 | Cytosolic DNA-sensing pathway | 5.86E-05 | 4 | P01584, P01568, Q13546, Q8NHW4 | IL1B, IFNA21, RIPK1, CCL4L2 | More | |
Medroxyprogesterone-acetate | hsa04650 | Natural killer cell mediated cytotoxicity | 2.02E-03 | 9 | P16298, P50591, O60880, P20963, Q02750, Q13241, P26718, P26717, P26715 | PPP3CB, TNFSF10, SH2D1A, CD247, MAP2K1, KLRD1, KLRK1, KLRC2, KLRC1 | More | |
Medroxyprogesterone-acetate | hsa04657 | IL-17 signaling pathway | 3.31E-02 | 3 | P49841, P14780, P01375 | GSK3B, MMP9, TNF | More | |
Medroxyprogesterone-acetate | hsa04658 | Th1 and Th2 cell differentiation | 3.54E-05 | 11 | Q04759, P07766, P20963, P09693, P19174, Q14765, P23771, Q9UL17, P14784, P13765, Q13761 | PRKCQ, CD3E, CD247, CD3G, PLCG1, STAT4, GATA3, TBX21, IL2RB, HLA-DOB, RUNX3 | More | |
Medroxyprogesterone-acetate | hsa04659 | Th17 cell differentiation | 1.41E-04 | 13 | P25963, Q04759, P19174, P14784, P13765, Q9UL17, P23771, P84022, Q13485, P08238, P07766, P09693, P20963 | NFKBIA, PRKCQ, PLCG1, IL2RB, HLA-DOB, TBX21, GATA3, SMAD3, SMAD4, HSP90AB1, CD3E, CD3G, CD247 | More | |
Medroxyprogesterone-acetate | hsa04660 | T cell receptor signaling pathway | 1.00E-02 | 7 | Q9UDY8, Q04759, P10747, Q08881, P20963, P09693, P01732 | MALT1, PRKCQ, CD28, ITK, CD247, CD3G, CD8A | More | |
Medroxyprogesterone-acetate | hsa04662 | B cell receptor signaling pathway | 8.32E-05 | 5 | P42338, P60033, P07948, P21854, Q8N149 | PIK3CB, CD81, LYN, CD72, LILRA2 | More | |
Medroxyprogesterone-acetate | hsa04664 | Fc epsilon RI signaling pathway | 4.31E-05 | 4 | P42338, P07948, P19174, P09917 | PIK3CB, LYN, PLCG1, ALOX5 | More | |
Medroxyprogesterone-acetate | hsa04666 | Fc gamma R-mediated phagocytosis | 1.73E-02 | 3 | P07948, P42338, P19174 | LYN, PIK3CB, PLCG1 | More | |
Medroxyprogesterone-acetate | hsa04668 | TNF signaling pathway | 4.74E-02 | 3 | Q99941, P01584, O95429 | CREBL1, IL1B, BAG4 | More | |
Medroxyprogesterone-acetate | hsa04713 | Circadian entrainment | 2.44E-03 | 6 | P0DP24, Q13557, P62873, Q08828, P51828, P63092 | CALM2, CAMK2D, GNB1, ADCY1, ADCY7, GNAS | More | |
Medroxyprogesterone-acetate | hsa04714 | Thermogenesis | 1.25E-02 | 3 | P15336, P63261, Q9Y478 | ATF2, ACTG1, PRKAB1 | More | |
Medroxyprogesterone-acetate | hsa04720 | Long-term potentiation | 7.69E-04 | 7 | Q13557, P16298, P0DP24, P51812, P18848, Q08828, Q02750 | CAMK2D, PPP3CB, CALM2, RPS6KA3, ATF4, ADCY1, MAP2K1 | More | |
Medroxyprogesterone-acetate | hsa04722 | Neurotrophin signaling pathway | 4.87E-02 | 3 | P42338, P19174, Q92529 | PIK3CB, PLCG1, SHC3 | More | |
Medroxyprogesterone-acetate | hsa04723 | Retrograde endocannabinoid signaling | 4.94E-02 | 2 | P48169, P62873 | GABRA4, GNB1 | More | |
Medroxyprogesterone-acetate | hsa04724 | Glutamatergic synapse | 1.32E-04 | 6 | P43003, P63092, P62873, P63218, P50151, P15104 | SLC1A3, GNAS, GNB1, GNG5, GNG10, GLUL | More | |
Medroxyprogesterone-acetate | hsa04725 | Cholinergic synapse | 1.56E-03 | 7 | Q08828, P51828, P63218, P50151, P18848, Q13557, P42338 | ADCY1, ADCY7, GNG5, GNG10, ATF4, CAMK2D, PIK3CB | More | |
Medroxyprogesterone-acetate | hsa04726 | Serotonergic synapse | 2.45E-03 | 5 | P63092, P62873, P63218, P50151, P09917 | GNAS, GNB1, GNG5, GNG10, ALOX5 | More | |
Medroxyprogesterone-acetate | hsa04727 | GABAergic synapse | 6.57E-03 | 3 | P63218, P50151, P15104 | GNG5, GNG10, GLUL | More | |
Medroxyprogesterone-acetate | hsa04728 | Dopaminergic synapse | 2.67E-02 | 5 | Q99941, P18848, Q13557, P0DP24, O15516 | CREBL1, ATF4, CAMK2D, CALM2, CLOCK | More | |
Medroxyprogesterone-acetate | hsa04730 | Long-term depression | 1.56E-02 | 2 | Q14344, P07948 | GNA13, LYN | More | |
Medroxyprogesterone-acetate | hsa04750 | Inflammatory mediator regulation of TRP channels | 4.53E-04 | 5 | P01584, Q08828, P51828, Q13557, P0DP24 | IL1B, ADCY1, ADCY7, CAMK2D, CALM2 | More | |
Medroxyprogesterone-acetate | hsa04910 | Insulin signaling pathway | 2.44E-03 | 6 | P22694, P06737, Q92529, Q13370, P42338, P49841 | PRKACB, PYGL, SHC3, PDE3B, PIK3CB, GSK3B | More | |
Medroxyprogesterone-acetate | hsa04911 | Insulin secretion | 2.95E-05 | 5 | Q08828, P51828, Q99941, P18848, Q13557 | ADCY1, ADCY7, CREBL1, ATF4, CAMK2D | More | |
Medroxyprogesterone-acetate | hsa04912 | GnRH signaling pathway | 6.99E-03 | 5 | Q08828, P51828, P18848, Q13557, P0DP24 | ADCY1, ADCY7, ATF4, CAMK2D, CALM2 | More | |
Medroxyprogesterone-acetate | hsa04914 | Progesterone-mediated oocyte maturation | 1.58E-03 | 6 | Q17RY0, P42338, Q13370, P08238, P51812, Q02750 | CPEB4, PIK3CB, PDE3B, HSP90AB1, RPS6KA3, MAP2K1 | More | |
Medroxyprogesterone-acetate | hsa04915 | Estrogen signaling pathway | 7.27E-04 | 7 | Q99941, P51828, P42338, Q92529, P07900, P08238, P11142 | CREBL1, ADCY7, PIK3CB, SHC3, HSP90AA1, HSP90AB1, HSPA8 | More | |
Medroxyprogesterone-acetate | hsa04916 | Melanogenesis | 7.61E-03 | 4 | Q13557, P0DP24, Q08828, P51828 | CAMK2D, CALM2, ADCY1, ADCY7 | More | |
Medroxyprogesterone-acetate | hsa04918 | Thyroid hormone synthesis | 4.47E-03 | 5 | Q08828, P51828, Q99941, P18848, P02768 | ADCY1, ADCY7, CREBL1, ATF4, ALB | More | |
Medroxyprogesterone-acetate | hsa04919 | Thyroid hormone signaling pathway | 7.11E-03 | 4 | P49841, P22694, O60244, Q9NVC6 | GSK3B, PRKACB, MED14, MED17 | More | |
Medroxyprogesterone-acetate | hsa04920 | Adipocytokine signaling pathway | 2.80E-02 | 2 | Q06124, Q9Y478 | PTPN11, PRKAB1 | More | |
Medroxyprogesterone-acetate | hsa04922 | Glucagon signaling pathway | 4.23E-02 | 4 | P22694, P06737, Q12778, Q14643 | PRKACB, PYGL, FOXO1, ITPR1 | More | |
Medroxyprogesterone-acetate | hsa04923 | Regulation of lipolysis in adipocytes | 3.64E-02 | 2 | Q13370, P42338 | PDE3B, PIK3CB | More | |
Medroxyprogesterone-acetate | hsa04924 | Renin secretion | 1.04E-02 | 3 | P22694, P07550, Q14643 | PRKACB, ADRB2, ITPR1 | More | |
Medroxyprogesterone-acetate | hsa04925 | Aldosterone synthesis and secretion | 8.00E-06 | 7 | Q99941, P18848, Q08828, P51828, P0DP24, Q13557, P23634 | CREBL1, ATF4, ADCY1, ADCY7, CALM2, CAMK2D, ATP2B4 | More | |
Medroxyprogesterone-acetate | hsa04926 | Relaxin signaling pathway | 1.31E-03 | 5 | P42338, P63218, P50151, P49767, Q92529 | PIK3CB, GNG5, GNG10, VEGFC, SHC3 | More | |
Medroxyprogesterone-acetate | hsa04927 | Cortisol synthesis and secretion | 4.16E-03 | 4 | Q99941, P18848, Q08828, P51828 | CREBL1, ATF4, ADCY1, ADCY7 | More | |
Medroxyprogesterone-acetate | hsa04928 | Parathyroid hormone synthesis, secretion and action | 3.92E-03 | 8 | Q14643, Q08828, P51828, P22694, P23771, Q99941, P18848, P10415 | ITPR1, ADCY1, ADCY7, PRKACB, GATA3, CREBL1, ATF4, BCL2 | More | |
Medroxyprogesterone-acetate | hsa04931 | Insulin resistance | 1.94E-02 | 3 | P01375, P49841, P06737 | TNF, GSK3B, PYGL | More | |
Medroxyprogesterone-acetate | hsa04932 | Non-alcoholic fatty liver disease | 3.45E-02 | 5 | P18848, O75460, P01584, P12074, O15239 | ATF4, ERN1, IL1B, COX6A1, NDUFA1 | More | |
Medroxyprogesterone-acetate | hsa04933 | AGE-RAGE signaling pathway in diabetic complications | 1.47E-03 | 6 | P84022, Q13485, P10415, P42338, P49767, P19174 | SMAD3, SMAD4, BCL2, PIK3CB, VEGFC, PLCG1 | More | |
Medroxyprogesterone-acetate | hsa04934 | Cushing syndrome | 2.69E-06 | 6 | Q99941, P18848, Q08828, P51828, O15169, Q13557 | CREBL1, ATF4, ADCY1, ADCY7, AXIN1, CAMK2D | More | |
Medroxyprogesterone-acetate | hsa04935 | Growth hormone synthesis, secretion and action | 3.41E-03 | 7 | P19174, Q08828, P51828, Q99941, P18848, P42338, Q92529 | PLCG1, ADCY1, ADCY7, CREBL1, ATF4, PIK3CB, SHC3 | More | |
Medroxyprogesterone-acetate | hsa04940 | Type I diabetes mellitus | 1.87E-02 | 2 | P48023, P01375 | FASLG, TNF | More | |
Medroxyprogesterone-acetate | hsa04964 | Proximal tubule bicarbonate reclamation | 4.88E-02 | 1 | P49448 | GLUD2 | More | |
Medroxyprogesterone-acetate | hsa04970 | Salivary secretion | 3.54E-02 | 3 | Q08828, P51828, P0DP24 | ADCY1, ADCY7, CALM2 | More | |
Medroxyprogesterone-acetate | hsa04971 | Gastric acid secretion | 2.95E-05 | 5 | Q08828, P51828, P15311, P0DP24, Q13557 | ADCY1, ADCY7, VIL2, CALM2, CAMK2D | More | |
Medroxyprogesterone-acetate | hsa04972 | Pancreatic secretion | 3.65E-02 | 2 | P63092, P61586 | GNAS, RHOA | More | |
Medroxyprogesterone-acetate | hsa04975 | Fat digestion and absorption | 9.50E-04 | 1 | O14494 | PLPP1 | More | |
Medroxyprogesterone-acetate | hsa04976 | Bile secretion | 2.44E-02 | 2 | P22694, P08183 | PRKACB, ABCB1 | More | |
Medroxyprogesterone-acetate | hsa05010 | Alzheimer disease | 2.62E-04 | 14 | Q92542, O15239, P05496, P12074, Q00535, O75460, P0DP24, P01584, P18848, O15169, P05141, P45880, P28070, P43686 | NCSTN, NDUFA1, ATP5G1, COX6A1, CDK5, ERN1, CALM2, IL1B, ATF4, AXIN1, SLC25A5, VDAC2, PSMB4, PSMC4 | More | |
Medroxyprogesterone-acetate | hsa05012 | Parkinson disease | 7.90E-03 | 9 | O15239, P12074, P05141, O75460, P18848, P28070, P43686, P0DP24, Q13557 | NDUFA1, COX6A1, SLC25A5, ERN1, ATF4, PSMB4, PSMC4, CALM2, CAMK2D | More | |
Medroxyprogesterone-acetate | hsa05016 | Huntington disease | 3.54E-02 | 8 | O15239, P12074, P24928, P62487, P05141, O75460, P28070, P43686 | NDUFA1, COX6A1, POLR2A, POLR2G, SLC25A5, ERN1, PSMB4, PSMC4 | More | |
Medroxyprogesterone-acetate | hsa05020 | Prion disease | 1.76E-03 | 12 | P01584, P46531, P11142, O15239, P05496, P12074, P18848, P05141, P45880, P28070, P43686, Q99941 | IL1B, NOTCH1, HSPA8, NDUFA1, ATP5G1, COX6A1, ATF4, SLC25A5, VDAC2, PSMB4, PSMC4, CREBL1 | More | |
Medroxyprogesterone-acetate | hsa05022 | Pathways of neurodegeneration - multiple diseases | 1.74E-03 | 13 | O15239, P12074, Q8TEV9, O75460, P18848, P05141, Q00535, O15169, P01584, P0DP24, Q13557, P28070, P43686 | NDUFA1, COX6A1, SMCR8, ERN1, ATF4, SLC25A5, CDK5, AXIN1, IL1B, CALM2, CAMK2D, PSMB4, PSMC4 | More | |
Medroxyprogesterone-acetate | hsa05030 | Cocaine addiction | 3.54E-02 | 3 | Q00535, Q99941, P18848 | CDK5, CREBL1, ATF4 | More | |
Medroxyprogesterone-acetate | hsa05031 | Amphetamine addiction | 7.61E-03 | 4 | P0DP24, Q13557, Q99941, P18848 | CALM2, CAMK2D, CREBL1, ATF4 | More | |
Medroxyprogesterone-acetate | hsa05032 | Morphine addiction | 9.19E-06 | 8 | P62873, P63218, P50151, Q13370, P48169, P78334, P63092, P32298 | GNB1, GNG5, GNG10, PDE3B, GABRA4, GABRE, GNAS, GRK4 | More | |
Medroxyprogesterone-acetate | hsa05034 | Alcoholism | 2.05E-05 | 7 | Q13547, Q93077, P58876, P62807, Q16778, O60814, P68431 | HDAC1, HIST1H2AC, H2BC5, HIST1H2BC, HIST2H2BE, H2BC12, H3C1; H3C2; H3C3; H3C4; H3C6; H3C7; H3C8; H3C10; H3C11; H3C12 | More | |
Medroxyprogesterone-acetate | hsa05100 | Bacterial invasion of epithelial cells | 3.64E-02 | 2 | P42338, Q92529 | PIK3CB, SHC3 | More | |
Medroxyprogesterone-acetate | hsa05130 | Pathogenic Escherichia coli infection | 9.80E-03 | 4 | Q92974, P63261, Q06124, O95487 | ARHGEF2, ACTG1, PTPN11, SEC24B | More | |
Medroxyprogesterone-acetate | hsa05132 | Salmonella infection | 5.76E-04 | 7 | P25963, Q13546, Q13489, P10415, Q9BQS8, O60282, P68371 | NFKBIA, RIPK1, BIRC3, BCL2, FYCO1, KIF5C, TUBB2C | More | |
Medroxyprogesterone-acetate | hsa05142 | Chagas disease | 2.26E-02 | 3 | P01375, P30679, P48023 | TNF, GNA15, FASLG | More | |
Medroxyprogesterone-acetate | hsa05143 | African trypanosomiasis | 2.72E-02 | 2 | P01375, P48023 | TNF, FASLG | More | |
Medroxyprogesterone-acetate | hsa05145 | Toxoplasmosis | 2.78E-02 | 3 | P25963, P10415, Q13489 | NFKBIA, BCL2, BIRC3 | More | |
Medroxyprogesterone-acetate | hsa05150 | Staphylococcus aureus infection | 1.83E-02 | 3 | P59665, P59666, P12838 | DEFA1; DEFA1B, DEFA3, DEFA4 | More | |
Medroxyprogesterone-acetate | hsa05161 | Hepatitis B | 8.49E-03 | 4 | P25963, Q13485, P10415, P84022 | NFKBIA, SMAD4, BCL2, SMAD3 | More | |
Medroxyprogesterone-acetate | hsa05162 | Measles | 3.91E-02 | 4 | P14784, P07766, P42338, P11142 | IL2RB, CD3E, PIK3CB, HSPA8 | More | |
Medroxyprogesterone-acetate | hsa05163 | Human cytomegalovirus infection | 4.51E-07 | 19 | P42338, P62873, P63218, P50151, P0DP24, Q14344, P61586, Q8NHW4, Q08828, P51828, P23458, P01584, P61073, Q13651, Q99941, P18848, P63092, P30101, P61769 | PIK3CB, GNB1, GNG5, GNG10, CALM2, GNA13, RHOA, CCL4L2, ADCY1, ADCY7, JAK1, IL1B, CXCR4, IL10RA, CREBL1, ATF4, GNAS, PDIA3, B2M | More | |
Medroxyprogesterone-acetate | hsa05167 | Kaposi sarcoma-associated herpesvirus infection | 6.22E-04 | 9 | P42338, P62879, P63218, P50151, P19174, P16298, Q02750, P07948, P0CG47 | PIK3CB, GNB2, GNG5, GNG10, PLCG1, PPP3CB, MAP2K1, LYN, UBB | More | |
Medroxyprogesterone-acetate | hsa05169 | Epstein-Barr virus infection | 3.34E-02 | 5 | P42338, P07948, P30101, Q13761, P07766 | PIK3CB, LYN, PDIA3, RUNX3, CD3E | More | |
Medroxyprogesterone-acetate | hsa05170 | Human immunodeficiency virus 1 infection | 1.36E-04 | 11 | P42338, Q02750, P62879, P63218, P50151, P16298, Q05397, P30101, P19174, P07766, P20333 | PIK3CB, MAP2K1, GNB2, GNG5, GNG10, PPP3CB, PTK2, PDIA3, PLCG1, CD3E, TNFRSF1B | More | |
Medroxyprogesterone-acetate | hsa05171 | Coronavirus disease - COVID-19 | 4.47E-02 | 2 | Q9UHA3, O14786 | RSL24D1, NRP1 | More | |
Medroxyprogesterone-acetate | hsa05200 | Pathways in cancer | 3.05E-02 | 8 | P42338, P08238, P19174, P49767, P63218, P50151, Q14344, P14784 | PIK3CB, HSP90AB1, PLCG1, VEGFC, GNG5, GNG10, GNA13, IL2RB | More | |
Medroxyprogesterone-acetate | hsa05202 | Transcriptional misregulation in cancer | 2.34E-03 | 13 | Q12778, Q13315, P14780, P27930, Q16548, P11215, O15550, P05164, P08246, Q9C0K0, Q13547, P12980, P24522 | FOXO1, ATM, MMP9, IL1R2, BCL2A1, ITGAM, UTX, MPO, ELA2, BCL11B, HDAC1, LYL1, GADD45A | More | |
Medroxyprogesterone-acetate | hsa05203 | Viral carcinogenesis | 1.22E-03 | 6 | Q13547, Q15283, P58876, P62807, Q16778, O60814 | HDAC1, RASA2, H2BC5, HIST1H2BC, HIST2H2BE, H2BC12 | More | |
Medroxyprogesterone-acetate | hsa05204 | Chemical carcinogenesis | 1.48E-02 | 2 | P78417, P11712 | GSTO1, CYP2C9 | More | |
Medroxyprogesterone-acetate | hsa05206 | MicroRNAs in cancer | 2.97E-03 | 6 | P15311, P21860, P61978, P46531, P63279, P22105 | VIL2, ERBB3, HNRPK, NOTCH1, UBE2I, TNXB | More | |
Medroxyprogesterone-acetate | hsa05210 | Colorectal cancer | 1.78E-02 | 3 | P84022, Q13485, P10415 | SMAD3, SMAD4, BCL2 | More | |
Medroxyprogesterone-acetate | hsa05211 | Renal cell carcinoma | 1.06E-02 | 2 | Q06124, Q99814 | PTPN11, EPAS1 | More | |
Medroxyprogesterone-acetate | hsa05212 | Pancreatic cancer | 3.52E-02 | 2 | P84022, Q13485 | SMAD3, SMAD4 | More | |
Medroxyprogesterone-acetate | hsa05213 | Endometrial cancer | 3.79E-02 | 2 | O15169, Q02750 | AXIN1, MAP2K1 | More | |
Medroxyprogesterone-acetate | hsa05214 | Glioma | 9.49E-03 | 3 | Q92529, P42338, P19174 | SHC3, PIK3CB, PLCG1 | More | |
Medroxyprogesterone-acetate | hsa05215 | Prostate cancer | 4.87E-02 | 3 | Q9NRA1, P08238, P42338 | PDGFC, HSP90AB1, PIK3CB | More | |
Medroxyprogesterone-acetate | hsa05218 | Melanoma | 3.64E-02 | 2 | Q9NRA1, P42338 | PDGFC, PIK3CB | More | |
Medroxyprogesterone-acetate | hsa05220 | Chronic myeloid leukemia | 1.25E-02 | 3 | Q13485, P25963, P84022 | SMAD4, NFKBIA, SMAD3 | More | |
Medroxyprogesterone-acetate | hsa05222 | Small cell lung cancer | 1.50E-02 | 3 | Q13489, P10415, P25963 | BIRC3, BCL2, NFKBIA | More | |
Medroxyprogesterone-acetate | hsa05226 | Gastric cancer | 4.33E-03 | 5 | Q02750, O15169, P84022, Q13485, P10415 | MAP2K1, AXIN1, SMAD3, SMAD4, BCL2 | More | |
Medroxyprogesterone-acetate | hsa05230 | Central carbon metabolism in cancer | 1.12E-02 | 1 | P11413 | G6PD | More | |
Medroxyprogesterone-acetate | hsa05231 | Choline metabolism in cancer | 1.17E-03 | 4 | P42338, Q9NRA1, P19174, P23743 | PIK3CB, PDGFC, PLCG1, DGKA | More | |
Medroxyprogesterone-acetate | hsa05235 | PD-L1 expression and PD-1 checkpoint pathway in cancer | 2.84E-02 | 5 | P20963, P09693, O60603, P10747, Q04759 | CD247, CD3G, TLR2, CD28, PRKCQ | More | |
Medroxyprogesterone-acetate | hsa05321 | Inflammatory bowel disease | 1.17E-03 | 5 | O60603, P13765, Q14765, Q9UL17, P23771 | TLR2, HLA-DOB, STAT4, TBX21, GATA3 | More | |
Medroxyprogesterone-acetate | hsa05322 | Systemic lupus erythematosus | 4.80E-06 | 7 | P09871, Q93077, P58876, P62807, Q16778, O60814, P68431 | C1S, HIST1H2AC, H2BC5, HIST1H2BC, HIST2H2BE, H2BC12, H3C1; H3C2; H3C3; H3C4; H3C6; H3C7; H3C8; H3C10; H3C11; H3C12 | More | |
Medroxyprogesterone-acetate | hsa05323 | Rheumatoid arthritis | 1.60E-02 | 4 | P13765, P10747, P09341, O60603 | HLA-DOB, CD28, CXCL1, TLR2 | More | |
Medroxyprogesterone-acetate | hsa05330 | Allograft rejection | 2.72E-02 | 2 | P48023, P01375 | FASLG, TNF | More | |
Medroxyprogesterone-acetate | hsa05332 | Graft-versus-host disease | 3.29E-04 | 6 | P13765, P48023, P10747, P01375, P26715, Q13241 | HLA-DOB, FASLG, CD28, TNF, KLRC1, KLRD1 | More | |
Medroxyprogesterone-acetate | hsa05415 | Diabetic cardiomyopathy | 3.59E-02 | 1 | P11413 | G6PD | More | |